Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02232516
Title Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Northwestern University
Indications

angioimmunoblastic T-cell lymphoma

anaplastic large cell lymphoma

mature T-cell and NK-cell lymphoma

mycosis fungoides

peripheral T-cell lymphoma

Therapies

Lenalidomide + Romidepsin

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
Yale University New Haven Connecticut 06520 United States Details
Northwestern University Chicago Illinois 60611 United States Details
Weill Cornell Medicine New York New York 10021 United States Details
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field